Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Devices Must Show Best Clinical Outcomes Under ACO, Medical Home Pilots

This article was originally published in The Gray Sheet

Executive Summary

Device makers will be under increased pressure to prove that their products provide the best clinical outcomes among alternatives as CMS tests out new reimbursement models under the health care reform law

You may also be interested in...



CMS Plans To Draft Accountable Care Organization Regulations This Fall

Physicians, hospital associations and patient advocates want more opportunities to present their views as CMS moves forward with its accountable care organization demonstration projects as required by the new health care reform law

CMS Plans To Draft Accountable Care Organization Regulations This Fall

Physicians, hospital associations and patient advocates want more opportunities to present their views as CMS moves forward with its accountable care organization demonstration projects as required by the new health care reform law

CMS In Brief

Coverage with evidence for stem cell transplants?: CMS proposes May 6 to allow coverage with evidence development for allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome, a group of diverse blood disorders in which the bone marrow does not produce enough healthy, functioning blood cells (1"The Gray Sheet" Nov. 30, 2009). The proposed coverage memo outlines criteria for prospective controlled clinical studies, including the need to address specified treatment outcomes and to adhere to strict standards of scientific integrity. CMS is taking comments through June 5 and plans a final rule by Aug. 4

Related Content

Topics

UsernamePublicRestriction

Register

MT028878

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel